The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $127.52

Today's change+0.26 +0.20%
Updated May 23 4:00 PM EDT. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $127.52

Today's change+0.26 +0.20%
Updated May 23 4:00 PM EDT. Delayed by at least 15 minutes.

Johnson & Johnson up (U.S.)$0.26

Johnson & Johnson closed up Tuesday by (U.S.)$0.26 or 0.20% to (U.S.)$127.52. Over the last five days, shares are unchanged, but are currently 1.15% below its 52-week high. This security has underperformed the S&P 500 by 3.41% during the last year.

Key company metrics

  • Open(U.S.) $127.31
  • Previous close(U.S.) $127.26
  • High(U.S.) $128.15
  • Low(U.S.) $127.31
  • Bid / Ask-- / --
  • YTD % change+10.68%
  • Volume3,973,025
  • Average volume (10-day)5,921,170
  • Average volume (1-month)5,526,633
  • Average volume (3-month)6,572,759
  • 52-week range(U.S.) $109.32 to (U.S.) $129.00
  • Beta0.80
  • Trailing P/E21.44×
  • P/E 1 year forward17.90×
  • Forward PEG2.75×
  • Indicated annual dividend(U.S.) $3.36
  • Dividend yield2.63%
  • Trailing EPS(U.S.) $5.95
Updated May 23 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.12%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 02, 201704/02/2017Jan 01, 201701/01/2017Oct 02, 201610/02/2016Jul 03, 201607/03/2016
Revenue17,76618,10617,82018,482
Total other revenue--------
Total revenue17,76618,10617,82018,482
Gross profit12,38412,59012,33713,153
Total cost of revenue5,3825,5165,4835,329
Total operating expense12,19113,78212,53913,578
Selling / general / administrative4,7375,3094,7725,176
Research & development2,0652,6402,1792,263
Depreciation / amortization--------
Interest expense (income), net operating204184192190
Unusual expense (income)161298109170
Other operating expenses, total-202-110-63573
Operating income5,5754,3245,2814,904
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5,5754,3245,2814,904
Income after tax4,4223,8144,2723,997
Income tax, total1,1535101,009907
Net income4,4223,8144,2723,997
Total adjustments to net income--------
Net income before extra. items4,4223,8144,2723,997
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4,4223,8144,2723,997
Inc. avail. to common incl. extra. items4,4223,8144,2723,997
Diluted net income4,4223,8144,2723,997
Dilution adjustment--------
Diluted weighted average shares2,7552,7662,7852,794
Diluted EPS excluding extraordinary itemsvalue per share1.611.381.531.43
Dividends per sharevalue per share0.800.800.800.80
Diluted normalized EPSvalue per share1.651.501.581.65